Chas McKhann - 05 May 2022 Form 4 Insider Report for Apollo Endosurgery, Inc.

Role: President and CEO, Director
Signature: /s/ Brian Szymczak - Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 05 May 2022
Net transactions value: -$360,717
Form type: 4
Filing time: 09 May 2022, 16:31:56 UTC
Previous filing: 20 Aug 2021
Next filing: 16 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APEN	Common Stock	Tax liability	$360,717	-66,553	-10%	$5.42	577,273	05 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction is not a sale of shares by the Reporting Person in the open market. Instead, this represents shares that have been withheld by the Issuer to satisfy the Reporting Person's income tax and withholding obligation in connection with the vesting of the second tranche of previously reported performance-based vesting restricted stock units reported on the Form 4 dated March 12, 2021. This net settlement was approved by the Issuer's compensation committee.

Content

This transaction is not a sale of shares by the Reporting Person in the open market. Instead, this represents shares that have been withheld by the Issuer to satisfy the Reporting Person's income tax and withholding obligation in connection with the vesting of the second tranche of previously reported performance-based vesting restricted stock units reported on the Form 4 dated March 12, 2021. This net settlement was approved by the Issuer's compensation committee.